Literature DB >> 11229983

Axis I psychiatric comorbidity and its relationship to historical illness variables in 288 patients with bipolar disorder.

S L McElroy1, L L Altshuler, T Suppes, P E Keck, M A Frye, K D Denicoff, W A Nolen, R W Kupka, G S Leverich, J R Rochussen, A J Rush, R M Post.   

Abstract

OBJECTIVE: Bipolar disorder often co-occurs with other axis I disorders, but little is known about the relationships between the clinical features of bipolar illness and these comorbid conditions. Therefore, the authors assessed comorbid lifetime and current axis I disorders in 288 patients with bipolar disorder and the relationships of these comorbid disorders to selected demographic and historical illness variables.
METHOD: They evaluated 288 outpatients with bipolar I or II disorder, using structured diagnostic interviews and clinician-administered and self-rated questionnaires to determine the diagnosis of bipolar disorder, comorbid axis I disorder diagnoses, and demographic and historical illness characteristics.
RESULTS: One hundred eighty-seven (65%) of the patients with bipolar disorder also met DSM-IV criteria for at least one comorbid lifetime axis I disorder. More patients had comorbid anxiety disorders (N=78, 42%) and substance use disorders (N=78, 42%) than had eating disorders (N=9, 5%). There were no differences in comorbidity between patients with bipolar I and bipolar II disorder. Both lifetime axis I comorbidity and current axis I comorbidity were associated with earlier age at onset of affective symptoms and syndromal bipolar disorder. Current axis I comorbidity was associated with a history of development of both cycle acceleration and more severe episodes over time.
CONCLUSIONS: Patients with bipolar disorder often have comorbid anxiety, substance use, and, to a lesser extent, eating disorders. Moreover, axis I comorbidity, especially current comorbidity, may be associated with an earlier age at onset and worsening course of bipolar illness. Further research into the prognostic and treatment response implications of axis I comorbidity in bipolar disorder is important and is in progress.

Entities:  

Mesh:

Year:  2001        PMID: 11229983     DOI: 10.1176/appi.ajp.158.3.420

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  124 in total

1.  Comorbid anxiety and substance use disorders associated with a lower use of mood stabilisers in patients with rapid cycling bipolar disorder: a descriptive analysis of the cross-sectional data of 566 patients.

Authors:  K Gao; D E Kemp; C Conroy; S J Ganocy; R L Findling; J R Calabrese
Journal:  Int J Clin Pract       Date:  2010-02       Impact factor: 2.503

Review 2.  BDNF function as a potential mediator of bipolar disorder and post-traumatic stress disorder comorbidity.

Authors:  J J Rakofsky; K J Ressler; B W Dunlop
Journal:  Mol Psychiatry       Date:  2011-09-20       Impact factor: 15.992

Review 3.  Staging bipolar disorder.

Authors:  Eduard Vieta; M Reinares; A R Rosa
Journal:  Neurotox Res       Date:  2010-05-12       Impact factor: 3.911

4.  Evidence for the continuous latent structure of mania in the Epidemiologic Catchment Area from multiple latent structure and construct validation methodologies.

Authors:  J J Prisciandaro; J E Roberts
Journal:  Psychol Med       Date:  2010-05-27       Impact factor: 7.723

5.  Positive and Negative Activation in the Mood Disorder Questionnaire: Associations With Psychopathology and Emotion Dysregulation in a Clinical Sample.

Authors:  Ryan W Carpenter; Kasey Stanton; Noah N Emery; Mark Zimmerman
Journal:  Assessment       Date:  2019-05-29

6.  Anxiety comorbidity in bipolar spectrum disorders: the mediational role of perfectionism in prospective depressive symptoms.

Authors:  Jared K O'Garro-Moore; Ashleigh Molz Adams; Lyn Y Abramson; Lauren B Alloy
Journal:  J Affect Disord       Date:  2014-11-21       Impact factor: 4.839

7.  Impact of substance use disorders on recovery from episodes of depression in bipolar disorder patients: prospective data from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD).

Authors:  Michael J Ostacher; Roy H Perlis; Andrew A Nierenberg; Joseph Calabrese; Jonathan P Stange; Ihsan Salloum; Roger D Weiss; Gary S Sachs
Journal:  Am J Psychiatry       Date:  2009-12-15       Impact factor: 18.112

8.  Further Evidence for Smoking and Substance Use Disorders in Youth With Bipolar Disorder and Comorbid Conduct Disorder.

Authors:  Timothy E Wilens; Joseph Biederman; MaryKate Martelon; Courtney Zulauf; Jesse P Anderson; Nicholas W Carrellas; Amy Yule; Janet Wozniak; Ronna Fried; Stephen V Faraone
Journal:  J Clin Psychiatry       Date:  2016-10       Impact factor: 4.384

9.  Acceptability, validity and reliability of the Structured Clinical Interview for the Spectrum of Substance Use (SCI-SUBS): a pilot study.

Authors:  A Sbrana; L Dell'Osso; C Gonnelli; P Impagnatiello; M R Doria; S Spagnolli; L Ravani; G B Cassano; E Frank; M K Shear; V J Grochocinski; P Rucci; J D Maser; J Endicott
Journal:  Int J Methods Psychiatr Res       Date:  2003       Impact factor: 4.035

10.  Comorbid anxiety in bipolar disorder: does it have an independent effect on suicidality?

Authors:  Atsuo Nakagawa; Michael F Grunebaum; Gregory M Sullivan; Dianne Currier; Steven P Ellis; Ainsley K Burke; David A Brent; J John Mann; Maria A Oquendo
Journal:  Bipolar Disord       Date:  2008-06       Impact factor: 6.744

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.